Nature of Operations (Schedule of Changes in Loss Per Share Due to Impact of Reverse Stock Split) (Details) - $ / shares		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Weighted Average Basic Shares Outstanding	[1]	302,756	13,400	160,751	13,298
Weighted Average Dilutive Shares Outstanding	[1]	302,756	13,400	160,751	13,298
Continuing operations - Basic	[1]	$ (11.77)	$ (173.81)	$ (128.25)	$ (395.75)
Discontinued operations - Basic	[1]		(2.54)		(90.71)
Continuing operations - Diluted	[1]	$ (11.77)	(173.81)	$ (128.25)	(395.75)
Discontinued operations - Diluted	[1]		$ (2.54)		$ (90.71)
As Previously Reported [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Weighted Average Basic Shares Outstanding			10,050,015		9,973,311
Weighted Average Dilutive Shares Outstanding			10,050,015		9,973,311
Continuing operations - Basic			$ (0.23)		$ (0.53)
Discontinued operations - Basic			(0.01)		(0.12)
Continuing operations - Diluted			(0.23)		(0.53)
Discontinued operations - Diluted			$ (0.01)		$ (0.12)
Impact of Reverse Stock [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Weighted Average Basic Shares Outstanding			(10,036,615)		(9,960,013)
Weighted Average Dilutive Shares Outstanding			(10,036,615)		(9,960,013)
Continuing operations - Basic			$ (173.58)		$ (395.22)
Discontinued operations - Basic			(2.53)		(90.59)
Continuing operations - Diluted			(173.58)		(395.22)
Discontinued operations - Diluted			$ (2.53)		$ (90.59)

[1] Prior period results have been adjusted to reflect the reverse stock split of the common stock at a ratio of 1-for-50 that became effective October 17, 2024 and the reverse stock split of the common stock at a ratio of 1-for-15 that became effective June 12, 2024. See Note 1, "Nature of Operations," for further details.